Last Updated: September 28, 2026

Mikart Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MIKART

MIKART has forty-three approved drugs.



Summary for Mikart
US Patents:0
Tradenames:12
Ingredients:11
NDAs:43

Drugs and US Patents for Mikart

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 207484-001 May 31, 2016 AB RX No Yes ⤷  Start Trial ⤷  Start Trial
Mikart HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 089271-001 Jul 16, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial
Mikart HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate CAPSULE;ORAL 089008-001 Feb 21, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial
Mikart HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 089697-001 Jan 28, 1992 DISCN No No ⤷  Start Trial ⤷  Start Trial
Mikart OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride SOLUTION;ORAL 202142-001 Nov 27, 2018 RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.